About US
Contact us
-
Gavi Vaccine Alliance seeks $7. 4bn to immunise 300 million peopleGavi, the Vaccine Alliance has initiated a $7.4bn fundraising drive to support the immunisation of 300 million children against 18 diseases, which could save up to eight million lives from 2021-25. D2019/9/2
-
Researchers find new drug with promise for malaria treatmentAn international research team led by the University of Glasgow has discovered a new drug that could kill the malaria-causing parasite, offering hope for the treatment of the disease. The drug stops2019/9/2
-
Study finds menopausal HRT drastically increases breast cancer riskResearch published in the Lancet has found that women taking hormone replacement therapy (HRT) to mitigate the symptoms of menopause for longer than a year have a significantly higher risk of breast2019/8/30
-
SpringWorks receives breakthrough status for desmoid tumour drugSpringWorks Therapeutics has received breakthrough therapy designation from the US Food and Drug Administration (FDA) for nirogacestat, an oral inhibitor for treating desmoid tumours or deep fibromat2019/8/30
-
ADCendo secures loan to advance ADCs for cancer treatmentADCendo has secured a loan amount to advance its novel antibody-drug conjugates (ADCs) that are being developed to treat cancers. The company secured the $1.48m convertible loan as part of the BioInn2019/8/29
-
AstraZeneca’s SLE drug performs well in Phase III trialAstraZeneca has announced anifrolumab met the primary endpoint of the Phase III Tulip trial studying 373 systemic lupus erythematosus (SLE) patients. The primary endpoint for the trial was reduction2019/8/29
-
Pharma cash rolls into Congress to defend an embattled industryIn the heat of the most ferocious battle over drug prices in years, pharmaceutical companies are showering U.S. senators with campaign cash as sweeping legislation heads toward the floor. In the firs2019/8/28
-
Novartis earlier acknowledged Zolgensma data errors to FDA but blamed them on poor reportingIn an inspection of the Illinois manufacturing facility for Novartis’ Zolgensma earlier this year, a team of top FDA officials met with AveXis staff. Although the assay that is now at the center of N2019/8/28
-
J&J found liable in Oklahoma opioid case and ordered to pay $572M; pledges to appealJohnson & Johnson fought hard against Oklahoma's claims the company played a "kingpin" role in the state’s opioid epidemic, but its lawyers fell short in those efforts after a six-week trial.On M2019/8/27
-
Can Lilly JAK Olumiant, plagued by side effects, really challenge Dupixent in dermatitis?Eli Lilly and Incyte's Olumiant has run up against safety hurdles in the past.But can those hurdles stop the drugmakers fromadding another feather to the drug’s cap, this time in the booming—and incr2019/8/27